Debra F. Weinstein, M.D., appointed executive vice dean for academic affairs, chief academic officer
On Thursday, the U-M Board of Regents approved the appointment of Debra F. Weinstein, M.D., as executive vice dean for academic affairs (EVDAA) in the U-M Medical School and chief academic officer for Michigan Medicine, effective Nov. 15.
Weinstein joins the leadership team after serving as vice president for graduate medical education at Mass General Brigham in Boston. In this role, she has been responsible for more than 300 GME programs with 2,400 residents and fellows, and has led local and national initiatives focused on enhancing GME. She also is an associate professor of medicine at Harvard Medical School and a senior physician in internal medicine/gastroenterology at Massachusetts General Hospital (MGH).
“I’m thrilled to be joining such a wonderful group of colleagues at a leading institution that I’ve long admired,” said Weinstein. “By having an outstanding medical school and health system integrated together, we are provided with great opportunities to help chart the future of medical education and health care — and improve health for the people of Michigan and beyond.”
After receiving her medical degree from Harvard Medical School, Weinstein completed clinical training in internal medicine and gastroenterology at MGH, was selected as chief resident, and served as associate chief and director of residency training in medicine prior to becoming the director of GME for MGH and the Brigham and Women’s hospitals and then vice president for GME for the Mass General Brigham (then “Partners”) health system.
At Harvard Medical School, she has contributed to key steering committees related to curriculum reform, the learning environment, LCME accreditation, continuing medical education and faculty affairs. Her scholarship has focused on GME innovation, and she is currently principal investigator of a $2 million “Reimagining Residency” grant from the American Medical Association focused on competency-based, time-variable GME.
Please welcome Weinstein to Michigan Medicine and thank Brian J. Zink, M.D., for his outstanding leadership as interim EVDAA and interim CAO since September 2020!